|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 19/08 | (2006.01) |
| (11) | Number of the document | 2195026 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08832690.5 |
| Date of filing the European patent application | 2008-09-17 | |
| (97) | Date of publication of the European application | 2010-06-16 |
| (45) | Date of publication and mention of the grant of the patent | 2013-12-25 |
| (46) | Date of publication of the claims translation | 2014-04-25 |
| (86) | Number | PCT/US2008/076679 |
| Date | 2008-09-17 |
| (87) | Number | WO 2009/039175 |
| Date | 2009-03-26 |
| (30) | Number | Date | Country code |
| 973024 P | 2007-09-17 | US |
| (72) |
PADHI, Ian, Desmond, US
JANG, Graham, Richard, US
|
| (73) |
Amgen, Inc,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai prieš sklerostiną |
| Anti-sclerostin antibodies |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 17 | 347.00 EUR |
| 2025-09-17 |